David M Vickers
Overview
Explore the profile of David M Vickers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vickers D, Hardie J, Eberspaecher S, Chaufan C, Pelech S
Front Public Health
. 2023 May;
11:1173673.
PMID: 37228725
No abstract available.
2.
Rennert-May E, Crocker A, DSouza A, Zhang Z, Chew D, Beall R, et al.
BMC Infect Dis
. 2023 May;
23(1):337.
PMID: 37208609
Background: Understanding the epidemiology of Coronavirus Disease of 2019 (COVID-19) in a local context is valuable for both future pandemic preparedness and potential increases in COVID-19 case volume, particularly due...
3.
Vickers D, Baral S, Mishra S, Kwong J, Sundaram M, Katz A, et al.
Int J Infect Dis
. 2022 Feb;
118:73-82.
PMID: 35202783
Background: Many studies have examined the effectiveness of non-pharmaceutical interventions (NPIs) on SARS-CoV-2 transmission worldwide. However, less attention has been devoted to understanding the limits of NPIs across the course...
4.
Vickers D, Osgood N
Theor Popul Biol
. 2014 Feb;
93:52-62.
PMID: 24513099
For curable infectious diseases, public health strategies such as treatment can effectively shorten an individual's infectious period, and thus limit their role in transmission. However, because treatment effectively eliminates antigen...
5.
Vickers D, Anonychuk A, De Wals P, Demarteau N, Bauch C
Vaccine
. 2013 Oct;
33(1):268-75.
PMID: 24103896
Objective: Advisory committees in Canada and the United States have updated recommendations for quadrivalent meningococcal conjugate vaccines against serogroups A, C, W135, and Y. Our objective was to evaluate optimally...
6.
Vickers D, Osgood N
BMC Infect Dis
. 2010 Mar;
10:70.
PMID: 20233416
Background: After initially falling in the face of intensified control efforts, reported rates of sexually transmitted chlamydia in many developed countries are rising. Recent hypotheses for this phenomenon have broadly...
7.
Haakensen M, Vickers D, Ziola B
BMC Microbiol
. 2009 Sep;
9:190.
PMID: 19735560
Background: Though important in the context of food microbiology and as potential pathogens in immuno-compromised humans, bacterial isolates belonging to the genus Pediococcus are best known for their association with...
8.
Vickers D, Zhang Q, Osgood N
PLoS One
. 2009 Sep;
4(9):e6886.
PMID: 19727394
Background: Chlamydia trachomatis is a common human pathogen that mediates disease processes capable of inflicting serious complications on reproduction. Aggressive inflammatory immune responses are thought to not only direct a...
9.
Vickers D, Osgood N
Theor Biol Med Model
. 2007 Dec;
4:49.
PMID: 18096067
Background: The desire to better understand the immuno-biology of infectious diseases as a broader ecological system has motivated the explicit representation of epidemiological processes as a function of immune system...